Sai Cancer And Research Services Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 08-07-2024
- Paid Up Capital ₹ 5.00 M
as on 08-07-2024
- Company Age 9 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 120.00 M
as on 08-07-2024
- Revenue 3.81%
(FY 2022)
- Profit 95.68%
(FY 2022)
- Ebitda 33.95%
(FY 2022)
- Net Worth 31.13%
(FY 2022)
- Total Assets -3.21%
(FY 2022)
About Sai Cancer And Research Services
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M.
The company currently has active open charges totaling ₹12.00 Cr.
Rohan Kharde, Bhushan Nikam, Atul Khalkar, and One other member serve as directors at the Company.
- CIN/LLPIN
U85100PN2015PTC154832
- Company No.
154832
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Apr 2015
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Ahmed Nagar, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Sai Cancer And Research Services?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rohan Kharde  | Director | 01-May-2015 | Current |
| Bhushan Nikam | Director | 01-May-2015 | Current |
| Atul Khalkar | Director | 01-May-2015 | Current |
| Satish Sonawane | Director | 27-Apr-2015 | Current |
Financial Performance and Corporate Structure Insights of Sai Cancer And Research Services.
Sai Cancer And Research Services Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 3.81% increase. The company also saw a substantial improvement in profitability, with a 95.68% increase in profit. The company's net worth Soared by an impressive increase of 31.13%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sai Cancer And Research Services?
In 2020, Sai Cancer And Research Services had a promoter holding of 25.00% and a public holding of 75.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sai Nuclear Private Limited
Active 2 years 6 monthsBhushan Nikam and Satish Sonawane are mutual person
Suryoday Cancer And Research Private Limited
Active 1 year 7 monthsBhushan Nikam and Satish Sonawane are mutual person
Varad Multispeciality Hospital Private Limited
Active 10 years 9 monthsSatish Sonawane is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 12 Mar 2020 | ₹5.00 Cr | Open |
Others Creation Date: 29 Apr 2016 | ₹7.00 Cr | Open |
How Many Employees Work at Sai Cancer And Research Services?
Unlock and access historical data on people associated with Sai Cancer And Research Services, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sai Cancer And Research Services, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sai Cancer And Research Services's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED_354462.webp){kind=small}
